17 patients)
12 studies, 7 RCTs, 5
observational (3390 patients)
7 studies, 6 RCTs, one
observational (2274 patients)

HL/S vs RFA
(RR, 1.65; 95% CI, 1.16 to 2.35;
I2 Â¼ 72.5%)
HL/S vs EVLA
(RR, 